Drugs / human umbilical cord mesenchymal stem cells
last change Jul 2026 re-read 2 minutes ago

human umbilical cord mesenchymal stem cells

Cell therapy

Developed for
cirrhosis of liver · acute respiratory distress syndrome · bronchopulmonary dysplasia · primary ovarian failure · type 2 diabetes mellitus · ischemic stroke · liver disorder · myocardial ischemia
+56 more · acute myocardial infarction · diabetic kidney disease · diabetic polyneuropathy · dilated cardiomyopathy · Duchenne muscular dystrophy · erectile dysfunction · heart failure · hepatitis B virus infection · intracerebral hemorrhage · lupus nephritis · multiple sclerosis · osteoarthritis, knee · stroke disorder · systemic lupus erythematosus · acute lung injury · adult acute respiratory distress syndrome · Alport syndrome · androgenetic alopecia · ankylosing spondylitis · articular cartilage disorder · autism · bile duct disorder · biliary atresia · chronic kidney disease · chronic obstructive pulmonary disease · corneal disorder · Crohn disease · decubitus ulcer · diabetes mellitus · graft versus host disease · hematopoietic and lymphoid cell neoplasm · hereditary ataxia · human papilloma virus infection · intermediate coronary syndrome · left ventricular failure · liver failure · lumbar disk degenerative disorder · lung disorder · nasal disorder · neuromyelitis optica · osteoarthritis · paraquat poisoning · pneumoconiosis · pneumonia · primary sclerosing cholangitis · retinitis pigmentosa · rheumatoid arthritis · spastic cerebral palsy · spinal cord injury · ST-elevation myocardial infarction · systemic sclerosis · systolic heart failure · ulcerative colitis · anterior cerebral artery infarction · middle cerebral artery infarction · posterior cerebral artery infarction
Investigated by
Shenzhen Beike Bio-Technology Co., Ltd. · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Chinese Academy of Sciences · Meridigen Biotech Co., Ltd. · Shanghai East Hospital · Affiliated Hospital to Academy of Military Medical Sciences
+100 more · Shenzhen Hornetcorn Bio-technology Company, LTD · Ever Supreme Bio Technology Co., Ltd. · Ivy Institute of Stem Cells Co. Ltd · Asia Cell Therapeutics (Shanghai) Co., Ltd. · Beijing 302 Hospital · Children's Hospital of Chongqing Medical University · Sclnow Biotechnology Co., Ltd. · Fifth Affiliated Hospital of Guangzhou Medical University · Indian Council of Medical Research · Institute of Liver and Biliary Sciences, India · Nanjing Medical University · Nanjing University Medical College Affiliated Wuxi Second Hospital · PT. Prodia Stem Cell Indonesia · Shenzhen Wingor Biotechnology Co., Ltd. · The Second Affiliated Hospital of Kunming Medical University · The Second Hospital University of South China · The Second Hospital of Nanjing Medical University · Xuzhou Medical University · A.O. Ospedale Papa Giovanni XXIII · Ankara University · Ankara Yildirim Beyazıt University · Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. · Assistance Publique - Hôpitaux de Paris · Association for the Handicapped Of Jinan · Associazione Italiana per la Ricerca sul Cancro · Atigen-Cell and Tissue Center · Beijing Tiantan Hospital · Beijing Tuohua Weiye Biotechnology Co., Ltd. · Beijing YouAn Hospital · Bright Cell, Inc. · Changchun Tuohua Pharmaceutical Co., Ltd. · Chinese PLA General Hospital · CytoMed & Beike · Dr Cipto Mangunkusumo General Hospital · Dr. Sami Ulus Children's Hospital · First Affiliated Hospital of Fujian Medical University · Futian People's Hospital · Fuzhou General Hospital · Guangzhou Saliai Stem Cell Science and Technology Co. Ltd. · Guangzhou Women and Children's Medical Center · Hacettepe University · Hormozgan University of Medical Sciences · Indonesia University · Jiangsu Topcel-KH Pharmaceutical Co., Ltd. · Jinan Hospital for Infectious Diseases · Leilei Zhu · Liaocheng People's Hospital · Limin Rong · MED Institute Inc. · Marie Hudson, MD · McGill University Health Centre/Research Institute of the McGill University Health Centre · Medical University of South Carolina · Min Long · Nanfang Hospital, Southern Medical University · Necmi Kadıoğlu Hospital · No.85 Hospital, Changning, Shanghai, China · Peking University People's Hospital · RenJi Hospital · Roberto Bolli · Rumah Sakit Pusat Angkatan Darat Gatot Soebroto · Shandong Jiaotong Hospital · Shandong Qilu Stem Cells Engineering Co., Ltd. · Shanghai Changzheng Hospital · Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Shanghai Life Science & Technology · Shanghai Public Health Clinical Center · Shenzhen Third People's Hospital · Shulan (Hangzhou) Hospital · Signature Biologics, LLC · Southern Medical University, China · Southwest Hospital, China · State-Financed Health Facility "Samara Regional Medical Center Dinasty" · Sun Yat-sen University · Tang Zhouping · all 106 on the full record

Trials 95 · started per year

today
2
3
2
4
2
2
9
8
2
8
5
8
5
5
8
8
7
4
1
1
200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT04125329 Apr 2020 → Sep 2024 diabetic kidney disease Yan'an Affiliated Hospital of Kunming Medical University Unknown No outcome recorded
Phase 0 NCT05442437 Sep 2019 → Jul 2022 hepatitis B virus infection Zhongnan Hospital Completed No outcome recorded
Phase 125 trials
Phase 1 NCT06589271 Dec 2026 → Jun 2027 lumbar disk degenerative disorder Sclnow Biotechnology Co., Ltd. Suspended No outcome recorded
Phase 1 NCT05494723 Dec 2026 → Jan 2028 expected Bright Cell, Inc. Not yet recruiting No outcome recorded
Phase 1 NCT03902067 Dec 2024 → Dec 2025 acute myocardial infarction, left ventricular failure Shanghai Life Science & Technology Withdrawn No outcome recorded
Phase 1 NCT04347967 Jan → Sep 2024 adult acute respiratory distress syndrome Meridigen Biotech Co., Ltd. Unknown No outcome recorded
Phase 1 NCT05962762 Aug 2023 → Dec 2026 expected ankylosing spondylitis Asia Cell Therapeutics (Shanghai) Co., Ltd. Not yet recruiting No outcome recorded
Phase 1 NCT05983627 Aug 2023 → Jun 2025 overdue acute respiratory distress syndrome Asia Cell Therapeutics (Shanghai) Co., Ltd. Not yet recruiting No outcome recorded
Phase 1 NCT04893174 Sep 2022 → Sep 2024 osteoarthritis, knee Meridigen Biotech Co., Ltd. Unknown No outcome recorded
Phase 1 NCT04914403 Sep 2021 → Dec 2024 Meridigen Biotech Co., Ltd. Unknown No outcome recorded
Phase 1 NCT04434768 Dec 2020 → Feb 2026 overdue stroke disorder Ever Supreme Bio Technology Co., Ltd. Active not recruiting No outcome recorded
Phase 1 NCT04206007 Jun 2020 → Dec 2023 chronic obstructive pulmonary disease Meridigen Biotech Co., Ltd. Unknown No outcome recorded
Phase 1/245 trials
Phase 1/2 NCT07452822 Feb 2026 → Mar 2027 expected Jiangsu Topcel-KH Pharmaceutical Co., Ltd. Not yet recruiting No outcome recorded
Phase 1/2 NCT07041801 Jun 2025 → Sep 2027 expected systemic lupus erythematosus Shenzhen Beike Bio-Technology Co., Ltd. Recruiting No outcome recorded
Phase 1/2 NCT07413978 Apr 2025 → Dec 2027 expected acute respiratory distress syndrome Changchun Tuohua Pharmaceutical Co., Ltd. Recruiting No outcome recorded
Phase 1/2 NCT06862388 Mar 2025 → Feb 2027 expected intracerebral hemorrhage Tang Zhouping Not yet recruiting No outcome recorded
Phase 1/2 NCT07413549 Feb 2025 → Dec 2026 expected cirrhosis of liver Beijing Tuohua Weiye Biotechnology Co., Ltd. Recruiting No outcome recorded
Phase 1/2 NCT06610773 Mar 2024 → Sep 2025 overdue human papilloma virus infection Shanghai East Hospital Recruiting No outcome recorded
Phase 1/2 NCT06302582 Feb → Nov 2024 decubitus ulcer Liaocheng People's Hospital Unknown No outcome recorded
Phase 1/2 NCT07439848 Dec 2023 → Dec 2026 expected acute respiratory distress syndrome PT. Prodia Stem Cell Indonesia Recruiting No outcome recorded
Phase 1/2 NCT05985863 Sep 2023 → Dec 2026 expected liver disorder Beijing 302 Hospital Recruiting No outcome recorded
Phase 1/2 NCT05532943 Sep 2023 → Oct 2028 expected multiple sclerosis Ever Supreme Bio Technology Co., Ltd. Recruiting No outcome recorded
Phase 210 trials
Phase 2 NCT07131306 Jan 2027 → Aug 2031 expected liver disorder Institute of Liver and Biliary Sciences, India Not yet recruiting No outcome recorded
Phase 2 NCT07183761 Oct 2025 → Apr 2028 expected diabetic polyneuropathy Min Long Recruiting No outcome recorded
Phase 2 NCT07084012 Aug 2025 → Mar 2026 overdue ischemic stroke Shenzhen Wingor Biotechnology Co., Ltd. Recruiting No outcome recorded
Phase 2 NCT06145035 Mar 2024 → Jan 2028 expected myocardial ischemia Roberto Bolli Recruiting No outcome recorded
Phase 2 NCT06147986 Sep 2023 → Jun 2027 expected ST-elevation myocardial infarction Ever Supreme Bio Technology Co., Ltd. Recruiting No outcome recorded
Phase 2 NCT03816852 Oct 2018 → Dec 2026 primary ovarian failure Sclnow Biotechnology Co., Ltd. Suspended No outcome recorded
Phase 2 NCT03529136 Jun 2018 → Dec 2019 cirrhosis of liver Shandong Qilu Stem Cells Engineering Co., Ltd. Unknown No outcome recorded
Phase 2 NCT03795974 Jul 2017 → Oct 2019 spastic cerebral palsy Tehran University of Medical Sciences Unknown No outcome recorded
Phase 2 NCT02580019 Feb → Dec 2016 stroke disorder Affiliated Hospital to Academy of Military Medical Sciences Unknown No outcome recorded
Phase 2 NCT01539902 Feb 2012 → Mar 2013 lupus nephritis CytoMed & Beike Unknown No outcome recorded
Phase 2/33 trials
Phase 2/3 NCT05909488 May 2026 → Jul 2027 expected retinitis pigmentosa PT. Prodia Stem Cell Indonesia Not yet recruiting No outcome recorded
Phase 2/3 NCT06731192 Jan 2025 → Jun 2026 overdue Alport syndrome Guangzhou Women and Children's Medical Center Not yet recruiting No outcome recorded
Phase 2/3 NCT02223897 Jul 2014 → Jun 2017 bile duct disorder Yang Yang Unknown No outcome recorded
Phase 33 trials
Phase 3 NCT07075315 Jan 2028 → Dec 2031 expected liver disorder Institute of Liver and Biliary Sciences, India Not yet recruiting No outcome recorded
Phase 3 NCT05631717 Oct 2022 → Jun 2025 lupus nephritis, systemic lupus erythematosus The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Unknown No outcome recorded
Phase 3 NCT04738981 Feb 2021 → May 2022 graft versus host disease Peking University People's Hospital Completed No outcome recorded
Phase not applicable6 trials
NCT06751199 Dec 2024 → Jul 2026 overdue diabetes mellitus Shanghai Changzheng Hospital Recruiting No outcome recorded
NCT06697080 Jun → Sep 2024 overdue androgenetic alopecia Nanfang Hospital, Southern Medical University Active not recruiting No outcome recorded
NCT06564740 Jun 2024 → May 2026 overdue biliary atresia, fibrotic liver disease Necmi Kadıoğlu Hospital Recruiting No outcome recorded
NCT05262829 Feb 2022 → Aug 2024 Crohn disease Shanghai East Hospital Unknown No outcome recorded
NCT05160831 Jan 2022 → Jan 2023 osteoarthritis, knee Southwest Hospital, China Unknown No outcome recorded
NCT05106972 Dec 2021 → Dec 2024 cirrhosis of liver Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. Unknown No outcome recorded
Phase not stated1 trial
NCT06579352 Duchenne muscular dystrophy MED Institute Inc. Available No outcome recorded
Also used as a comparator or background therapy in 2 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT04093336 Comparator Jan 2019 → Dec 2024 anterior cerebral artery infarction, middle cerebral artery infarction, posterior cerebral artery infarction Shanghai East Hospital Unknown No outcome recorded
Phase 1/2 NCT02635464 Comparator Oct 2015 → Aug 2019 myocardial ischemia Chinese Academy of Sciences Completed No outcome recorded

Evidence & citations 40 cited values

Every value below carries the sentence it was read from. 110 sources stand behind the page.

FieldValueCited text
Known as human umbilical cord mesenchymal stem cells Human umbilical cord mesenchymal stem cells (UC-MSCs) are multifunctional stem cells with properties such as self-renewal, multidirectional differentiation potential, tissue...” NCT06862388
41

“The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation” NCT02947191

“Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosis” NCT03826433

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients.” PMID 22320928 Mar 2012

Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Women With Primary Ovarian Insufficiency (POI)” NCT03033277

“allogeneic human umbilical cord mesenchymal stem cells (hUC-MSCs) in collagen scaffold injecting in the infarct region.” NCT02635464

Human umbilical cord mesenchymal stem cells were transplanted by intravenous infusion” NCT03816852

human umbilical cord mesenchymal stem cells (hUC-MSCs) transplantation” NCT06589271

human umbilical cord mesenchymal stem cells (hUC-MSCs) injection” NCT07183761

Human umbilical cord mesenchymal stem cells (hUC-MSC)” NCT06731192

Human Umbilical Cord Mesenchymal Stem Cells Injection” NCT07413978

NCT04093336

NCT05631717

NCT02652351

NCT02790762

NCT01610440

NCT03237442

NCT04282928

NCT05962762

NCT04125329

NCT06751199

NCT01360164

NCT07452822

NCT06579352

NCT05160831

NCT02291926

NCT01364246

NCT04314011

NCT01742533

NCT05262829

NCT04216849

NCT05948982

NCT04992832

NCT02481440

NCT02283879

NCT07413549

NCT01443689

NCT06302582

NCT05983627

NCT01343511

NCT06697080

NCT02580019

Known as 19#iSCLife-LC “Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosis” NCT03826433
Known as aCell Inj. “A Clinical Trial to Evaluate the Safety, Tolerance and Efficacy of aCell Inj. of Allogeneic UC-MSCs in Patients With Decompensated Hepatitis B Cirrhosis” NCT05948982
Known as Cellistem “Patients with heart failure and reduced ejection fraction under optimal medical treatment were randomized to intravenous infusion of allogenic UC-MSCs (Cellistem, Cells for...” PMID 28974553 Sep 2017
Known as Hu-MSCs “The aim of the study was to examine treatment of cerebral hemorrhages with bone-marrow or human umbilical cord-derived mesenchymal stem cells (BMSCs or Hu-MSCs) and...” PMID 28101148 Oct 2016
1

“Platelet-rich plasma (PRP) combined with human umbilical cord mesenchymal stem cells (huMSCs)” NCT06302582

Known as hUC Mesenchymal Stem Cells hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis” NCT03826433
Known as HUC-MSC “The volunteers of the experimental group will be given peripheral intravenously a dose of 1.5\*10\^6/kg human umbilical cord mesenchymal stem cell (HUC-MSC) at 0,8,16,24,32 week.” NCT04216849
6

“OBJECTIVE: We evaluate the efficacy of human umbilical cord-derived mesenchymal stem cell (hUC-MSC) for the treatment of lupus nephritis (LN).” PMID 28478399 May 2017

“human umbilical cord mesenchymal stem cell(hUC-MSC) for cerebral hemorrhage sequela” NCT02283879

NCT02643823

NCT02579148

NCT06731192

NCT05985863

Known as hUC-MSCs “Human umbilical cord mesenchymal stem cells (hUCMSCs) and human cord blood mononuclear cells (hCBMNCs) have been shown to have the ability to modulate the immune response and...” NCT01443689
26

“Human umbilical cord mesenchymal stem cells (hUC-MSCs) and human cord blood mononuclear cells (hCB-MNCs) have been shown to have the ability to modulate the immune response and...” NCT01343511

“Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been evidenced to improve motor function, increase muscle strength and reduce abnormal levels of related enzymes” NCT01610440

“The collection of human umbilical cord derived mesenchymal stem cells (hUC-MSCs) is non-invasive and there are no medical ethics issues in obtaining them.” NCT05962762

“Human Umbilical Cord Mesenchymal Stem Cell Injection (hUCMSCs) in the Treatment of Patients With Moderate to Severe Systemic Lupus Erythematosus” NCT07041801

“single dose of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in patients with severe BPD.” PMID 37223507 Feb 2022

“human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) combined with platelet-rich plasma (PRP)” NCT06302582

“allogeneic human umbilical cord mesenchymal stem cells (HucMSCs or MSCs used in the following section)” NCT04093336

“intramyocardial delivery of human umbilical cord-derived mesenchymal stromal cells (HUC-MSCs)” PMID 32840230 Nov 2020

“human umbilical cord mesenchymal stem cells (hUC-MSCs) transplantation” NCT06589271

“human umbilical cord mesenchymal stem cells (hUC-MSCs) injection” NCT07183761

“Human umbilical cord mesenchymal stem cells(HUC-MSCs)” NCT04314011

NCT03033277

NCT02745808

NCT01342250

NCT02223897

NCT06610773

NCT02786017

NCT03873506

NCT03816852

NCT02635464

NCT02644447

NCT03774537

NCT02947191

NCT05507697

NCT07084012

NCT05442437

Known as human UC-MSCs human UC-MSCs: 0.2ml(about 2\*10\^6 cells) subconjunctival injection” NCT03237442
Known as human umbilical cord -derived mesenchymal stem cells “The study is designed to assess the safety and efficacy of allogeneic human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) with injectable collagen scaffold...” NCT02635464
5

“The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients...” NCT02786017

“This is a follow-up study to investigate the long-term safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs), for the treatment of BPD in...” NCT03873506

“single dose of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in patients with severe BPD.” PMID 37223507 Feb 2022

human umbilical cord -derived mesenchymal stem cells (hUC-MSCs)” NCT03774537

“Human Umbilical Cord-derived Mesenchymal Stem Cells (HUC-MSCs)” NCT02745808

Known as human umbilical cord mesenchymal stem cell Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial.” PMID 38925694 Jun 2024
Known as Human Umbilical Cord Mesenchymal Stem Cell Injection “The test drug used in this study is called Human Umbilical Cord Mesenchymal Stem Cell InjectionNCT05948982
Known as human umbilical cord MSC “Allogeneic human umbilical cord MSCs will be transplanted” NCT02323477
Known as human umbilical cord MSC injection “The infusion route of human umbilical cord MSC injection is the peripheral vein” NCT05948982
Known as human umbilical cord MSC injections “The human umbilical cord MSC injections used in this study have been studied by the National Health Care Commission (NHC)/Central Military Commission (CMC) General Directorate...” NCT05948982
Known as human umbilical cord MSCs “Non-clinical and other clinical studies suggest that human umbilical cord MSCs can alter the tissue microenvironment through paracrine mechanisms” NCT05948982
2

Human umbilical cord MSCs are transplanted three times by intravenous infusion(1×10\^6/kg) ,once every week,a total of three times.” NCT02442037

human umbilical cord MSCs in the treatment of refractory moderate-to-severe Crohn's disease” NCT05262829

Known as human umbilical cord-derived mesenchymal stromal cell human umbilical cord-derived mesenchymal stromal cell (hUC-MSC)-laden collagen hydrogel intramyocardial injection” PMID 32910197 Sep 2020
Known as human umbilical cord-derived mesenchymal stromal cells “intramyocardial delivery of human umbilical cord-derived mesenchymal stromal cells (HUC-MSCs)” PMID 32840230 Nov 2020
Known as human umbilical cord-derived MSCs “In this study, we aimed to evaluate the safety and efficacy of intravenous infusion of human umbilical cord-derived MSCs (HUC-MSCs) in patients with aging frailty.” PMID 38679727 Apr 2024
Known as MSC ClinicalTrials.gov intervention name — accepted as the source's own label NCT03795974
Known as MSCs “allogeneic human umbilical cord mesenchymal stem cells (HucMSCs or MSCs used in the following section)” NCT04093336
2

“human umbilical cord MSCs in the treatment of refractory moderate-to-severe Crohn's disease” NCT05262829

“treat POI patients wit human umbilical cord mesenchymal stem cells (MSCs).” NCT03816852

Known as UC-MSC “In this randomized clinical trial, we evaluated 1HMRS measures (N-acetyl aspartate [NAA], choline [Cho], creatine [Cr], myo-inositol [mI], NAA/Cho, and NAA/Cr) within...” PMID 42156830 May 2026
31

“RATIONALE: Umbilical cord-derived mesenchymal stem cells (UC-MSC) are easily accessible and expanded in vitro, possess distinct properties, and improve myocardial remodeling...” PMID 28974553 Sep 2017

“The aim of this study is to demonstrate the efficacy of Umbilical Cord-Derived Mesenchymal Stem Cell (UC-MSC) therapy in BA by planning a multicentric randomized controlled trial.” NCT06564740

“Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with active ulcerative colitis,randomized, single blind, controlled prospective study.” NCT02442037

“Safety and efficacy of umbilical-cord-derived mesenchymal stem cell (UC-MSC) in patients with paraquat poisoning induced lung injury” NCT02444858

“Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis” NCT05962762

“umbilical cord-derived MSCs (UC-MSC) can improve the longer term survival in patients with liver cirrhosis” NCT01220492

“umbilical cord-derived MSCs (UC-MSCs) treatment three times (at weeks 0, 1 and 2).” PMID 38925694 Jun 2024

“ucMSC 1 million/kg will be given once a week for 4 week .” NCT07075315

“umbilical-cord-derived mesenchymal stem cell (UC-MSC)” NCT02439541

“umbilical-cord-derived mesenchymal stem cell (UC-MSC)” NCT02444455

“Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC)” NCT06579352

“Umbilical Cord Mesenchymal Stem Cells (UC-MSC)” NCT05948982

NCT01844063

NCT03516006

NCT03943940

NCT03902067

NCT05512988

NCT07439848

NCT05106972

NCT01690247

NCT02439541

NCT04356287

NCT01739777

NCT05292625

NCT02444455

NCT04738981

NCT02032446

NCT04501341

NCT07131306

NCT05909488

NCT03529136

Known as UC-MSCs “This non-randomized, open-label, single center phase I/II trial investigated the safety and efficacy of combined transplantation of human cord blood mononuclear cells (CBMNCs)...” PMID 23978163 Aug 2013
8

“The trial aimed to evaluate the safety of three intravenous infusions of Umbilical Cord-derived MSCs (UC-MSCs) administered at six-week intervals in patients with heart failure...” PMID 41888108 Mar 2026

“Human umbilical cord mesenchymal stem cells (UC-MSCs) are multifunctional stem cells with properties such as self-renewal, multidirectional differentiation potential, tissue...” NCT06862388

“The objectives of this study were to assess the feasibility, efficacy, and potential toxicity of human umbilical cord mesenchymal stem cells (UCMSCs) therapy in patients with SCA.” PMID 23151076 Feb 2013

“Autologous bone marrow mononuclear cells (BM-MNCs) and allogeneic umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) under sterile conditions to treat this disease.” NCT03943940

“Bone-marrow mononuclear cells (BM-MNCs) and umbilical-cord tissue-derived mesenchymal stem cells (UC-MSCs) via its immunomodulatory properties” NCT04501341

“umbilical cord-derived MSCs (UC-MSCs) treatment three times (at weeks 0, 1 and 2).” PMID 38925694 Jun 2024

“umbilical cord-derived mesenchymal stromal cells (UC-MSCs)” NCT06145035

“umbilical cord derived mesenchymal stem cells (UC-MSCs)” NCT02439541

Known as UCT-MSC “This study assessed the safety and efficacy of intrathecal injection of umbilical cord tissue mesenchymal stem cells (UCT-MSC) in individuals with cerebral palsy (CP).” PMID 34362453 Aug 2021
Known as UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS “allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs)” NCT04325594
2

UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)” NCT02032446

NCT06145035